A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Yun Wang, Jørn Herrstedt, Hanne Havsteen, Rene DePoint Christensen, Mansoor Raza Mirza, Bente Lund, Johanna Maenpaa, Gunnar Kristensen

Research output: Contribution to journalJournal articleResearchpeer-review

5 Citations (Scopus)
Original languageEnglish
Article number937
JournalB M C Cancer
Issue number14
Publication statusPublished - 2014

Cite this